There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K31/5377
Jump to navigation
Jump to search
Pages in category "A61K31/5377"
The following 13 pages are in this category, out of 13 total.
2
- 20240024302. SOLUBLE EPOXIDE HYDROLASE (sEH) INHIBITORS AND DUAL COX/sEH INHIBITORS FOR THE TREATMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY simplified abstract (BETH ISRAEL DEACONESS MEDICAL CENTER, INC.)
- 20240024344. Methods For The Effective Treatment Of Metastatic Cancer simplified abstract (General Oncology, Inc.)
- 20240043445. Thienopyranones and Furanopyranones as Kinase, Bromodomain, and Checkpoint Inhibitors simplified abstract (SignalRx Pharmaceuticals, Inc.)
- 20240050439. 6-ARYL-4-MORPHOLIN-1-YLPYRIDONE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER AND DIABETES simplified abstract (Spring Bioscience AB)
- 20240050440. THERAPEUTIC TARGETS AND AGENTS FOR THE TREATMENT OF TRIOSEPHOSPHATE ISOMERASE (TPI) DEFICIENCY simplified abstract (University of Pittsburgh- Of The Commonwealth System of Higher Education)
B
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 29th, 2024
- Blockchain patent applications on February 8th, 2024
- Blockchain patent applications on January 25th, 2024
- Blockchain patent applications on March 28th, 2024
- Blockchain patent applications on March 7th, 2024